Search Results

Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs:British Society for Rheumatology guideline scope

• Authors : Tillett, William; Allen, Alexander; Tucker, Laura

Subjects: psoriatic_arthritis treatment biologics; bDMARDs targeted; tsDMARDs guideline management

• Source: Tillett, W, Allen, A, Tucker, L, Chandler, D, Ciurtin, C, Davis, C, Dick, A, Foulkes, A, Gullick, N, Helliwell, P, Jadon, D, Jones, G, Kyle, S, Madhok, V, McHugh, N, Parkinson, A, Raine, T, Siebert,

Record details

Matching-adjusted indirect comparison:secukinumab versus infliximab in biologic-naive patients with psoriatic arthritis

• Authors : Strand, Vibeke; McInnes, Iain B; Mease, Philip J

Subjects: comparative effectiveness; infliximab; matching-adjusted indirect comparison

• Source: Strand, V, McInnes, I B, Mease, P J, Nash, P, Thom, H, Kalyvas, C, Hunger, M, Gandhi, K, Pricop, L, Jugl, S & Choy, E 2019, 'Matching-adjusted indirect comparison : secukinumab versus infliximab in

Record details

Comparative effectiveness of secukinumab and etanercept in biologic-naïve patients with psoriatic arthritis assessed by matching-adjusted indirect comparison

• Authors : Mease, Philip J; Choy, Ernest; Nash, Peter

Subjects: Comparative effectiveness; etanercept; matching-adjusted indirect comparison

• Source: Mease, P J, Choy, E, Nash, P, Kalyvas, C, Hunger, M, Pricop, L, Gandhi, K, Jugl, S & Thom, H 2019, 'Comparative effectiveness of secukinumab and etanercept in biologic-naïve patients with

Record details

Matching-adjusted indirect comparison:secukinumab versus infliximab in biologic-naive patients with psoriatic arthritis

• Authors : Strand, Vibeke; McInnes, Iain B; Mease, Philip J

Subjects: comparative effectiveness; infliximab; matching-adjusted indirect comparison

• Source: Strand, V, McInnes, I B, Mease, P J, Nash, P, Thom, H, Kalyvas, C, Hunger, M, Gandhi, K, Pricop, L, Jugl, S & Choy, E 2019, 'Matching-adjusted indirect comparison : secukinumab versus infliximab in

Record details

An international multicentre analysis of current prescribing practices and shared decision-making in psoriatic arthritis

• Authors : Watson, Lily; Coyle, Conor; Whately-Smith, Caroline

• Source: Watson, L, Coyle, C, Whately-Smith, C, Brooke, M, Kiltz, U, Lubrano, E, Queiro, R, Trigos, D, Brandt-Juergens, J, Choy, E, D’angelo, S, Delle sedie, A, Dernis, E, Guis, S, Helliwell, P, Ho, P,

Record details

An international multicentre analysis of current prescribing practices and shared decision-making in psoriatic arthritis

• Authors : Watson, Lily; Coyle, Conor; Whately-Smith, Caroline

• Source: Watson, L, Coyle, C, Whately-Smith, C, Brooke, M, Kiltz, U, Lubrano, E, Queiro, R, Trigos, D, Brandt-Juergens, J, Choy, E, D’angelo, S, Delle sedie, A, Dernis, E, Guis, S, Helliwell, P, Ho, P,

Record details

Secukinumab Versus Adalimumab for Psoriatic Arthritis:Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison

• Authors : Nash, Peter; McInnes, Iain B; Mease, Philip J

Subjects: Adalimumab; Comparative effectiveness; Matching-Adjusted Indirect Comparison

• Source: Nash, P, McInnes, I B, Mease, P J, Thom, H, Hunger, M, Karabis, A, Gandhi, K, Mpofu, S & Jugl, S M 2018, 'Secukinumab Versus Adalimumab for Psoriatic

Record details

Secukinumab Versus Adalimumab for Psoriatic Arthritis:Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison

• Authors : Nash, Peter; McInnes, Iain B; Mease, Philip J

Subjects: Adalimumab; Comparative effectiveness; Matching-Adjusted Indirect Comparison

• Source: Nash, P, McInnes, I B, Mease, P J, Thom, H, Hunger, M, Karabis, A, Gandhi, K, Mpofu, S & Jugl, S M 2018, 'Secukinumab Versus Adalimumab for Psoriatic

Record details

Secukinumab for psoriatic arthritis:comparative effectiveness versus licensed biologics/apremilast: a network meta-analysis

• Authors : McInnes, Iain B; Nash, Peter; Ritchlin, Christopher

• Source: McInnes, I B, Nash, P, Ritchlin, C, Choy, E, Kantars, S, Thom, H, Ghandhi, K, Pricop, L & Jugl, S M 2018, 'Secukinumab for psoriatic

Record details

Secukinumab for psoriatic arthritis:comparative effectiveness versus licensed biologics/apremilast: a network meta-analysis

• Authors : McInnes, Iain B; Nash, Peter; Ritchlin, Christopher

• Source: McInnes, I B, Nash, P, Ritchlin, C, Choy, E, Kantars, S, Thom, H, Ghandhi, K, Pricop, L & Jugl, S M 2018, 'Secukinumab for psoriatic

Record details